US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms
A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval. Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […]
The kindness section highlights people helping people: strangers stepping in during emergencies, communities rallying around neighbors, small acts that ripple outward. These are not performative charity stories; they are moments where someone chose to act when they did not have to.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
From Turin comes a surgical world-first: the simultaneous transplant of a complete human macula, along with the cornea, …
American amphibian lovers will be jumping for joy at the news of 3,000 frogs and tadpoles from an endangered species bre…
Jack Gardner couldn’t believe his eyes when he saw the behemoth hooked on his fishing line. If he and his crew aboard Do…
110 years ago today, the National Park Service was created in the US. Guardians of 64 extraordinary places which documen…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →